Stroke Breakthrough
Dr. Tobinick has invented a breakthrough new treatment for stroke. Stroke may result in a damaging chronic inflammatory response in the brain tissue surrounding the stroke core, the so-called stroke penumbra. In the February 2011 issue of CNS Drugs, Dr. Tobinick documented rapid improvement in chronic neurological deficits following targeted administration of etanercept. For more information, see www.strokebreakthrough.com.
Scientific Publications
Dr. Tobinick's contributions to the medical literature include co-authorship of a medical textbook and more than 20 scientific articles that have published in peer-reviewed medical and scientific journals. These articles include recent reviews in the journals Expert Review of Neurotherapeutics, CNS Drugs, and Drug Discovery Today, as well as published articles in BMC Neurology, Current Alzheimer Research, and the Journal of Neuroinflammation.
Scientific Recognition
When reporting their scientific results, scientists will discuss and refer to previous publications in their articles. These citations to the scientific literature are an integral part of the scientific process. There have been hundreds of scientific citations to Dr. Tobinick's publications, including in the journals Brain Research, Molecular Pain, Nature Clinical Practice Neurology, Neurobiology of Aging, Neuroscience, Pharmacology and Therapeutics, Spine and F1000 Biology.